{"id":9257,"date":"2024-01-18T20:10:14","date_gmt":"2024-01-18T17:10:14","guid":{"rendered":"https:\/\/urbancare.clinic\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\/"},"modified":"2024-01-18T20:10:14","modified_gmt":"2024-01-18T17:10:14","slug":"die-auf-neurotechnologie-basierende-recoverix-behandlung-bietet-eine-sicherere-alternative-zu-medikamenten-fur-schlaganfall-und-ms-patienten","status":"publish","type":"post","link":"https:\/\/urbancare.clinic\/de\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\/","title":{"rendered":"Die auf Neurotechnologie basierende RecoveriX-Behandlung bietet eine sicherere Alternative zu Medikamenten f\u00fcr Schlaganfall- und MS-Patienten"},"content":{"rendered":"
<\/div>\n

Da jedes Jahr mehr Menschen an neurologischen Erkrankungen wie Schlaganfall und Multipler Sklerose (MS) leiden, ist das Bewusstsein f\u00fcr diese Erkrankungen und die Art und Weise, wie man sie behandelt oder behandelt, immer wichtiger geworden. Nach Angaben der Weltgesundheitsorganisation ist das lebenslange Risiko, einen Schlaganfall zu erleiden, gestiegen in den letzten 17 Jahren um 50% gestiegen<\/span><\/a>, wobei etwa jeder vierte Mensch im Laufe seines Lebens voraussichtlich einen Schlaganfall erleiden wird. In der Zwischenzeit, fast 3 Millionen Menschen <\/span><\/a>leiden weltweit an MS.<\/p>\n

Schlaganfall- und MS-Patienten haben aufgrund eingeschr\u00e4nkter Bewegungsf\u00e4higkeit und Muskelspastik, insbesondere in ihren Gliedma\u00dfen, h\u00e4ufig eine verminderte Lebensqualit\u00e4t. Die meisten Medikamente, die den Patienten verabreicht werden, sind nicht in der Lage, die beeintr\u00e4chtigten K\u00f6rperfunktionen wiederherzustellen. Vielmehr k\u00f6nnen diese nur eine Verschlechterung des Zustands des Patienten verhindern oder, im Falle von MS, den Verfall des Patienten verlangsamen. Orale antispastische Medikamente haben oft eine begrenzte Wirkung und kann Nebenwirkungen hervorrufen<\/span><\/a> wie Schw\u00e4che, Verwirrtheit und Schwindel. Bei manchen Patienten werden kleine Dosen Botulinumtoxin (Botox) in die Muskulatur gespritzt, um die Spastik zu lindern. Diese Behandlung ist nur etwa 12 Wochen lang wirksam, bevor sie wiederholt werden muss, was sowohl kostspielig als auch riskant sein kann.<\/p>\n

Im Gegensatz zu den meisten Medikamenten gegen Schlaganfall und MS auf dem Markt, RecoveriX<\/span><\/a>, eine Neurorehabilitationsbehandlung mit Gehirn-Computer-Schnittstelle, hilft nachweislich bei der Rehabilitation von Schlaganfall<\/span><\/a> Und Multiple Sklerose<\/span><\/a> Patienten. Entwickelt von einem in \u00d6sterreich ans\u00e4ssigen Unternehmen g.tec Medizintechnik<\/span><\/a>Mit \u201erecoveriX\u201c werden die Gliedma\u00dfen der Patienten elektrisch stimuliert, sodass sie nach einer Beeintr\u00e4chtigung durch neurologische Erkrankungen ihre Funktion wiedererlangen k\u00f6nnen. Der Patient sitzt vor einer Computereinheit und tr\u00e4gt ein EEG-Headset, das die Gehirnstr\u00f6me des Patienten liest. Der Monitor dient als Bewegungsf\u00fchrung f\u00fcr ihre Gliedma\u00dfen und die mit ihren Gliedma\u00dfen verbundenen Elektroden stimulieren die Muskeln elektrisch und bewirken eine Dorsalflexion der Gelenke. Jede Therapiesitzung dauert etwa eine Stunde, wobei ein RecoveriX-Behandlungsblock aus 25 Sitzungen besteht, idealerweise dreimal pro Woche.<\/p>\n

Wiederholte Verwendung von RecoveryiX <\/span><\/a>Es hat sich gezeigt, dass es Patienten dabei hilft, ihre Gliedma\u00dfen wieder zu benutzen, die Spastik zu reduzieren und die motorischen F\u00e4higkeiten zu verbessern. Dies kann zum Beispiel sein gezeigt<\/span><\/a> durch eine bessere Leistung im Neun-Loch-Peg-Test, einem Ma\u00df f\u00fcr feine manuelle Geschicklichkeit. Die Patienten zeigten au\u00dferdem eine bessere Konzentration, k\u00f6rperliche Leistungsf\u00e4higkeit, Kognition, Ged\u00e4chtnisleistung und Blasenkontrolle. Diese tragen zu einer verbesserten Lebensqualit\u00e4t bei und erm\u00f6glichen es den Patienten, die meisten Aktivit\u00e4ten auszuf\u00fchren, die sie nach einem Schlaganfall oder einer MS nicht mehr ausf\u00fchren konnten.<\/p>\n

Laut Dr. Christoph Guger, Mitbegr\u00fcnder und CEO von g.tec, hat \u201erecoveriX\u201c, das auf visueller und elektromuskul\u00e4rer Stimulation basiert, zahlreiche positive Effekte ohne nennenswerte negative Nebenwirkungen. Er f\u00fcgt hinzu, dass bei der Betrachtung klinischer Studien zu Medikamenten Tausende von Patienten den Nachweis einer bestimmten Wirkung des Medikaments ben\u00f6tigen. Da es sich bei der klinischen Studie um Tests an einer gro\u00dfen Anzahl von Personen handelt, bedeutet dies nicht, dass das Medikament f\u00fcr einen einzelnen Patienten ideal ist.<\/p>\n

Dar\u00fcber hinaus gibt es bei Multipler Sklerose je nach Patient und Art der MS rund 20 verschiedene Medikamente, die eingesetzt werden k\u00f6nnen. Nach einem Jahr Einnahme eines bestimmten Medikaments wird der Patient auf seine Wirksamkeit untersucht. Wenn das Medikament nicht das richtige f\u00fcr den Patienten ist, besteht die M\u00f6glichkeit, dass es die Situation nur verschlimmert, sagt Guger.<\/p>\n

Trotz der enormen positiven Auswirkungen neuer, technologiegest\u00fctzter Behandlungen wie RecoveriX weisen Guger darauf hin, dass \u00c4rzte manchmal z\u00f6gern, sie zu verschreiben. Auch einige Krankenkassen \u00fcbernehmen die Kosten f\u00fcr diese Behandlungen noch nicht. Laut Guger liegt dies daran, dass viele \u00c4rzte ausschlie\u00dflich auf Medikamente geschult waren und \u201erecoveriX\u201c w\u00e4hrend ihres Medizinstudiums noch nicht existierte. Er glaubt jedoch, dass mit der Zeit mehr Mediziner die Vorteile von RecoveryiX erkennen und es mit ihren Medikamenten und Behandlungspl\u00e4nen kombinieren werden. Dar\u00fcber hinaus werden Versicherungsgesellschaften mit der Kosten\u00fcbernahme f\u00fcr die RecoveryiX-Sitzungen beginnen, sobald sie die Daten sehen, dass es funktioniert und zu geringeren Versicherungsauszahlungskosten f\u00fchrt.<\/p>\n

Heute ist RecoveryiX in mehreren L\u00e4ndern in Europa, Asien-Pazifik, Nordamerika und Afrika verf\u00fcgbar und g.tec nutzt ein einzigartiges Franchisesystem, um die schnelle Verbreitung der Technologie zu erm\u00f6glichen. Guger setzt sich daf\u00fcr ein, dass mehr Menschen, die an Schlaganfall, MS und anderen neurologischen Erkrankungen leiden, Zugang zu \u201erecoveriX\u201c erhalten, sich selbst von den positiven Auswirkungen \u00fcberzeugen und es an andere Menschen weitergeben k\u00f6nnen, die es ben\u00f6tigen.<\/p>\n

Medizinische t\u00e4gliche Quelle<\/a><\/p>\n

","protected":false},"excerpt":{"rendered":"

<\/div>\n

Da jedes Jahr mehr Menschen an neurologischen Erkrankungen wie Schlaganfall und Multipler Sklerose (MS) leiden, ist das Bewusstsein f\u00fcr diese Erkrankungen und die Art und Weise, wie man sie behandelt oder behandelt, immer wichtiger geworden. Nach Angaben der Weltgesundheitsorganisation ist das lebenslange Risiko, einen Schlaganfall zu erleiden, gestiegen in den letzten 17 Jahren um 50% gestiegen<\/span><\/a>, wobei etwa jeder vierte Mensch im Laufe seines Lebens voraussichtlich einen Schlaganfall erleiden wird. In der Zwischenzeit, fast 3 Millionen Menschen <\/span><\/a>leiden weltweit an MS.<\/p>\n

Schlaganfall- und MS-Patienten haben aufgrund eingeschr\u00e4nkter Bewegungsf\u00e4higkeit und Muskelspastik, insbesondere in ihren Gliedma\u00dfen, h\u00e4ufig eine verminderte Lebensqualit\u00e4t. Die meisten Medikamente, die den Patienten verabreicht werden, sind nicht in der Lage, die beeintr\u00e4chtigten K\u00f6rperfunktionen wiederherzustellen. Vielmehr k\u00f6nnen diese nur eine Verschlechterung des Zustands des Patienten verhindern oder, im Falle von MS, den Verfall des Patienten verlangsamen. Orale antispastische Medikamente haben oft eine begrenzte Wirkung und kann Nebenwirkungen hervorrufen<\/span><\/a> wie Schw\u00e4che, Verwirrtheit und Schwindel. Bei manchen Patienten werden kleine Dosen Botulinumtoxin (Botox) in die Muskulatur gespritzt, um die Spastik zu lindern. Diese Behandlung ist nur etwa 12 Wochen lang wirksam, bevor sie wiederholt werden muss, was sowohl kostspielig als auch riskant sein kann.<\/p>\n

Im Gegensatz zu den meisten Medikamenten gegen Schlaganfall und MS auf dem Markt, RecoveriX<\/span><\/a>, eine Neurorehabilitationsbehandlung mit Gehirn-Computer-Schnittstelle, hilft nachweislich bei der Rehabilitation von Schlaganfall<\/span><\/a> Und Multiple Sklerose<\/span><\/a> Patienten. Entwickelt von einem in \u00d6sterreich ans\u00e4ssigen Unternehmen g.tec Medizintechnik<\/span><\/a>Mit \u201erecoveriX\u201c werden die Gliedma\u00dfen der Patienten elektrisch stimuliert, sodass sie nach einer Beeintr\u00e4chtigung durch neurologische Erkrankungen ihre Funktion wiedererlangen k\u00f6nnen. Der Patient sitzt vor einer Computereinheit und tr\u00e4gt ein EEG-Headset, das die Gehirnstr\u00f6me des Patienten liest. Der Monitor dient als Bewegungsf\u00fchrung f\u00fcr ihre Gliedma\u00dfen und die mit ihren Gliedma\u00dfen verbundenen Elektroden stimulieren die Muskeln elektrisch und bewirken eine Dorsalflexion der Gelenke. Jede Therapiesitzung dauert etwa eine Stunde, wobei ein RecoveriX-Behandlungsblock aus 25 Sitzungen besteht, idealerweise dreimal pro Woche.<\/p>\n

Wiederholte Verwendung von RecoveryiX <\/span><\/a>Es hat sich gezeigt, dass es Patienten dabei hilft, ihre Gliedma\u00dfen wieder zu benutzen, die Spastik zu reduzieren und die motorischen F\u00e4higkeiten zu verbessern. Dies kann zum Beispiel sein gezeigt<\/span><\/a> durch eine bessere Leistung im Neun-Loch-Peg-Test, einem Ma\u00df f\u00fcr feine manuelle Geschicklichkeit. Die Patienten zeigten au\u00dferdem eine bessere Konzentration, k\u00f6rperliche Leistungsf\u00e4higkeit, Kognition, Ged\u00e4chtnisleistung und Blasenkontrolle. Diese tragen zu einer verbesserten Lebensqualit\u00e4t bei und erm\u00f6glichen es den Patienten, die meisten Aktivit\u00e4ten auszuf\u00fchren, die sie nach einem Schlaganfall oder einer MS nicht mehr ausf\u00fchren konnten.<\/p>\n

Laut Dr. Christoph Guger, Mitbegr\u00fcnder und CEO von g.tec, hat \u201erecoveriX\u201c, das auf visueller und elektromuskul\u00e4rer Stimulation basiert, zahlreiche positive Effekte ohne nennenswerte negative Nebenwirkungen. Er f\u00fcgt hinzu, dass bei der Betrachtung klinischer Studien zu Medikamenten Tausende von Patienten den Nachweis einer bestimmten Wirkung des Medikaments ben\u00f6tigen. Da es sich bei der klinischen Studie um Tests an einer gro\u00dfen Anzahl von Personen handelt, bedeutet dies nicht, dass das Medikament f\u00fcr einen einzelnen Patienten ideal ist.<\/p>\n

Dar\u00fcber hinaus gibt es bei Multipler Sklerose je nach Patient und Art der MS rund 20 verschiedene Medikamente, die eingesetzt werden k\u00f6nnen. Nach einem Jahr Einnahme eines bestimmten Medikaments wird der Patient auf seine Wirksamkeit untersucht. Wenn das Medikament nicht das richtige f\u00fcr den Patienten ist, besteht die M\u00f6glichkeit, dass es die Situation nur verschlimmert, sagt Guger.<\/p>\n

Trotz der enormen positiven Auswirkungen neuer, technologiegest\u00fctzter Behandlungen wie RecoveriX weisen Guger darauf hin, dass \u00c4rzte manchmal z\u00f6gern, sie zu verschreiben. Auch einige Krankenkassen \u00fcbernehmen die Kosten f\u00fcr diese Behandlungen noch nicht. Laut Guger liegt dies daran, dass viele \u00c4rzte ausschlie\u00dflich auf Medikamente geschult waren und \u201erecoveriX\u201c w\u00e4hrend ihres Medizinstudiums noch nicht existierte. Er glaubt jedoch, dass mit der Zeit mehr Mediziner die Vorteile von RecoveryiX erkennen und es mit ihren Medikamenten und Behandlungspl\u00e4nen kombinieren werden. Dar\u00fcber hinaus werden Versicherungsgesellschaften mit der Kosten\u00fcbernahme f\u00fcr die RecoveryiX-Sitzungen beginnen, sobald sie die Daten sehen, dass es funktioniert und zu geringeren Versicherungsauszahlungskosten f\u00fchrt.<\/p>\n

Heute ist RecoveryiX in mehreren L\u00e4ndern in Europa, Asien-Pazifik, Nordamerika und Afrika verf\u00fcgbar und g.tec nutzt ein einzigartiges Franchisesystem, um die schnelle Verbreitung der Technologie zu erm\u00f6glichen. Guger setzt sich daf\u00fcr ein, dass mehr Menschen, die an Schlaganfall, MS und anderen neurologischen Erkrankungen leiden, Zugang zu \u201erecoveriX\u201c erhalten, sich selbst von den positiven Auswirkungen \u00fcberzeugen und es an andere Menschen weitergeben k\u00f6nnen, die es ben\u00f6tigen.<\/p>","protected":false},"author":2,"featured_media":9258,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"Default","format":"standard","meta":{"page_builder":"","fifu_image_url":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2024\/01\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients.jpg","fifu_image_alt":"","footnotes":""},"categories":[27],"tags":[],"class_list":["post-9257","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"yoast_head":"\nNeurotechnology-Based RecoveriX Treatment Provides Safer Alternative To Medications For Stroke And MS Patients - Urban Care Clinic<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/urbancare.clinic\/de\/die-auf-neurotechnologie-basierende-recoverix-behandlung-bietet-eine-sicherere-alternative-zu-medikamenten-fur-schlaganfall-und-ms-patienten\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Neurotechnology-Based RecoveriX Treatment Provides Safer Alternative To Medications For Stroke And MS Patients - Urban Care Clinic\" \/>\n<meta property=\"og:description\" content=\"With more people suffering from neurological conditions such as stroke and multiple sclerosis (MS) each year, awareness of these conditions and how to treat or manage them has become more important. According to the World Health Organization, the lifetime risk of developing a stroke has risen by 50% over the past 17 years, with around one in every four people expected to suffer a stroke in their lifetime. Meanwhile, close to 3 million people have MS worldwide.Stroke and MS patients are often left with a decreased quality of life, due to limited movement and muscle spasticity, particularly in their limbs. Most of the medications given to patients are unable to restore affected bodily functions. Instead, these can only prevent the patient's condition from deteriorating or, in the case of MS, slow down the patient's decline. Oral antispastic medications often provide limited effects and may induce side effects such as weakness, confusion and dizziness. For some patients, small doses of botulinum toxin (botox) are injected into the muscles to relieve the spasticity. This treatment is effective for only around 12 weeks, before it needs to be repeated, which can be both costly and risky.Unlike most medications for stroke and MS on the market, recoveriX, a brain-computer interface neurorehabilitation treatment, has been shown to aid in the rehabilitation of stroke and multiple sclerosis patients. Developed by Austria-based company g.tec medical engineering, recoveriX electrically stimulates patients' limbs, helping them regain function after being impaired by neurological conditions. The patient sits in front of a computer unit while wearing an EEG headset that reads the patient's brainwaves. The monitor serves as a movement guide for their limbs and the electrodes connected to their limbs provide electrical stimulation to muscles, causing dorsiflexion of the joints. Each therapy session lasts for around an hour, with one recoveriX treatment block consisting of 25 sessions, ideally three times a week.Repeated use of recoveriX has been shown to help patients recover the use of their limbs, with reduced spasticity and improved motor skills. For example, this can be demonstrated by better performance in the nine-hole peg test, a measure of fine manual dexterity. Patients have also shown better concentration, physical performance, cognition, memory and bladder control. These contribute to improved quality of life and allow patients to do most of the activities they couldn't after developing stroke or MS.According to g.tec co-founder and CEO, Dr. Christoph Guger, recoveriX, which relies on visual and electro-muscular stimulation has multiple positive effects without any significant negative side effects. He adds that looking at clinical studies for medication, there is a need for thousands of patients to prove that the medication has a certain effect. Because the clinical trial involves testing on a large number of people, this doesn't mean that the medication is ideal for an individual patient.Furthermore, for multiple sclerosis, there are around 20 different medications that can be used, depending on the patient and the type of MS. After one year of taking a certain medication, the patient is evaluated whether it is effective. If the medication isn't the right one for the patient, there is a chance that it could just make things worse, Guger says.Despite the huge positive impact of new, technology-enabled treatments such as recoveriX, Guger notes that doctors can sometimes be hesitant to prescribe them. Some insurance companies, as well, have yet to cover these treatments. According to Guger, this is because many physicians were trained solely on medication and recoveriX did not yet exist when they were in medical school. However, with time, he believes that more medical professionals will see the benefits of recoveriX and combine it with their medication and treatment regimens. Additionally, insurance companies will begin covering recoveriX sessions once they see the data that it works and results in lower insurance payout costs.Today, recoveriX is available in multiple countries across Europe, Asia-Pacific, North America and Africa and g.tec uses a unique franchise system to enable the rapid spread of the technology. Guger is fighting to ensure that more people suffering from stroke, MS and other neurological conditions will be able to access recoveriX and see for themselves its positive effects, as well as spread the word to other people who need it.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/urbancare.clinic\/de\/die-auf-neurotechnologie-basierende-recoverix-behandlung-bietet-eine-sicherere-alternative-zu-medikamenten-fur-schlaganfall-und-ms-patienten\/\" \/>\n<meta property=\"og:site_name\" content=\"Urban Care Clinic\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/urbancarezanzibar\" \/>\n<meta property=\"article:published_time\" content=\"2024-01-18T17:10:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/urbancare.clinic\/wp-content\/uploads\/2024\/01\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"1024\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Urban Care Clinic\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Verfasst von\" \/>\n\t<meta name=\"twitter:data1\" content=\"Urban Care Clinic\" \/>\n\t<meta name=\"twitter:label2\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data2\" content=\"4\u00a0Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\\\/\"},\"author\":{\"name\":\"Urban Care Clinic\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#\\\/schema\\\/person\\\/a304a61bcf298680ee41e2e9ae193930\"},\"headline\":\"Neurotechnology-Based RecoveriX Treatment Provides Safer Alternative To Medications For Stroke And MS Patients\",\"datePublished\":\"2024-01-18T17:10:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\\\/\"},\"wordCount\":727,\"publisher\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/urbancare.clinic\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients.jpg\",\"articleSection\":[\"Medical Daily\"],\"inLanguage\":\"de\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\\\/\",\"url\":\"https:\\\/\\\/urbancare.clinic\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\\\/\",\"name\":\"Neurotechnology-Based RecoveriX Treatment Provides Safer Alternative To Medications For Stroke And MS Patients - Urban Care Clinic\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/urbancare.clinic\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients.jpg\",\"datePublished\":\"2024-01-18T17:10:14+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/urbancare.clinic\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\\\/#primaryimage\",\"url\":\"https:\\\/\\\/urbancare.clinic\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients.jpg\",\"contentUrl\":\"https:\\\/\\\/urbancare.clinic\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients.jpg\",\"caption\":\"Neurotechnology-Based RecoveriX Treatment Provides Safer Alternative To Medications For Stroke And MS Patients\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/urbancare.clinic\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Neurotechnology-Based RecoveriX Treatment Provides Safer Alternative To Medications For Stroke And MS Patients\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#website\",\"url\":\"https:\\\/\\\/urbancare.clinic\\\/\",\"name\":\"Urban Care Clinic\",\"description\":\"Your Medical Healthcare Clinic in Zanzibar\",\"publisher\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/urbancare.clinic\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#organization\",\"name\":\"Urban Care Clinic Zanzibar\",\"alternateName\":\"Urban Care Clinic\",\"url\":\"https:\\\/\\\/urbancare.clinic\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/urbancare.clinic\\\/wp-content\\\/uploads\\\/2022\\\/07\\\/Urban-Care-Clinic-Logo-Trans-512x512-1.png\",\"contentUrl\":\"https:\\\/\\\/urbancare.clinic\\\/wp-content\\\/uploads\\\/2022\\\/07\\\/Urban-Care-Clinic-Logo-Trans-512x512-1.png\",\"width\":500,\"height\":500,\"caption\":\"Urban Care Clinic Zanzibar\"},\"image\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/urbancarezanzibar\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#\\\/schema\\\/person\\\/a304a61bcf298680ee41e2e9ae193930\",\"name\":\"Urban Care Clinic\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8f8b5f9c42679ce61ae24fd31561a4574502595c4b3428a4fdf92d929bf09352?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8f8b5f9c42679ce61ae24fd31561a4574502595c4b3428a4fdf92d929bf09352?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8f8b5f9c42679ce61ae24fd31561a4574502595c4b3428a4fdf92d929bf09352?s=96&d=mm&r=g\",\"caption\":\"Urban Care Clinic\"},\"url\":\"https:\\\/\\\/urbancare.clinic\\\/de\\\/author\\\/urban-care-clinic\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Neurotechnologiebasierte RecoveriX-Behandlung bietet sicherere Alternative zu Medikamenten f\u00fcr Schlaganfall- und MS-Patienten \u2013 Urban Care Clinic","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/urbancare.clinic\/de\/die-auf-neurotechnologie-basierende-recoverix-behandlung-bietet-eine-sicherere-alternative-zu-medikamenten-fur-schlaganfall-und-ms-patienten\/","og_locale":"de_DE","og_type":"article","og_title":"Neurotechnology-Based RecoveriX Treatment Provides Safer Alternative To Medications For Stroke And MS Patients - Urban Care Clinic","og_description":"With more people suffering from neurological conditions such as stroke and multiple sclerosis (MS) each year, awareness of these conditions and how to treat or manage them has become more important. According to the World Health Organization, the lifetime risk of developing a stroke has risen by 50% over the past 17 years, with around one in every four people expected to suffer a stroke in their lifetime. Meanwhile, close to 3 million people have MS worldwide.Stroke and MS patients are often left with a decreased quality of life, due to limited movement and muscle spasticity, particularly in their limbs. Most of the medications given to patients are unable to restore affected bodily functions. Instead, these can only prevent the patient's condition from deteriorating or, in the case of MS, slow down the patient's decline. Oral antispastic medications often provide limited effects and may induce side effects such as weakness, confusion and dizziness. For some patients, small doses of botulinum toxin (botox) are injected into the muscles to relieve the spasticity. This treatment is effective for only around 12 weeks, before it needs to be repeated, which can be both costly and risky.Unlike most medications for stroke and MS on the market, recoveriX, a brain-computer interface neurorehabilitation treatment, has been shown to aid in the rehabilitation of stroke and multiple sclerosis patients. Developed by Austria-based company g.tec medical engineering, recoveriX electrically stimulates patients' limbs, helping them regain function after being impaired by neurological conditions. The patient sits in front of a computer unit while wearing an EEG headset that reads the patient's brainwaves. The monitor serves as a movement guide for their limbs and the electrodes connected to their limbs provide electrical stimulation to muscles, causing dorsiflexion of the joints. Each therapy session lasts for around an hour, with one recoveriX treatment block consisting of 25 sessions, ideally three times a week.Repeated use of recoveriX has been shown to help patients recover the use of their limbs, with reduced spasticity and improved motor skills. For example, this can be demonstrated by better performance in the nine-hole peg test, a measure of fine manual dexterity. Patients have also shown better concentration, physical performance, cognition, memory and bladder control. These contribute to improved quality of life and allow patients to do most of the activities they couldn't after developing stroke or MS.According to g.tec co-founder and CEO, Dr. Christoph Guger, recoveriX, which relies on visual and electro-muscular stimulation has multiple positive effects without any significant negative side effects. He adds that looking at clinical studies for medication, there is a need for thousands of patients to prove that the medication has a certain effect. Because the clinical trial involves testing on a large number of people, this doesn't mean that the medication is ideal for an individual patient.Furthermore, for multiple sclerosis, there are around 20 different medications that can be used, depending on the patient and the type of MS. After one year of taking a certain medication, the patient is evaluated whether it is effective. If the medication isn't the right one for the patient, there is a chance that it could just make things worse, Guger says.Despite the huge positive impact of new, technology-enabled treatments such as recoveriX, Guger notes that doctors can sometimes be hesitant to prescribe them. Some insurance companies, as well, have yet to cover these treatments. According to Guger, this is because many physicians were trained solely on medication and recoveriX did not yet exist when they were in medical school. However, with time, he believes that more medical professionals will see the benefits of recoveriX and combine it with their medication and treatment regimens. Additionally, insurance companies will begin covering recoveriX sessions once they see the data that it works and results in lower insurance payout costs.Today, recoveriX is available in multiple countries across Europe, Asia-Pacific, North America and Africa and g.tec uses a unique franchise system to enable the rapid spread of the technology. Guger is fighting to ensure that more people suffering from stroke, MS and other neurological conditions will be able to access recoveriX and see for themselves its positive effects, as well as spread the word to other people who need it.","og_url":"https:\/\/urbancare.clinic\/de\/die-auf-neurotechnologie-basierende-recoverix-behandlung-bietet-eine-sicherere-alternative-zu-medikamenten-fur-schlaganfall-und-ms-patienten\/","og_site_name":"Urban Care Clinic","article_publisher":"https:\/\/www.facebook.com\/urbancarezanzibar","article_published_time":"2024-01-18T17:10:14+00:00","og_image":[{"url":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2024\/01\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients.jpg","width":1024,"height":1024,"type":"image\/jpeg"}],"author":"Urban Care Clinic","twitter_card":"summary_large_image","twitter_misc":{"Verfasst von":"Urban Care Clinic","Gesch\u00e4tzte Lesezeit":"4\u00a0Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/urbancare.clinic\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\/#article","isPartOf":{"@id":"https:\/\/urbancare.clinic\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\/"},"author":{"name":"Urban Care Clinic","@id":"https:\/\/urbancare.clinic\/#\/schema\/person\/a304a61bcf298680ee41e2e9ae193930"},"headline":"Neurotechnology-Based RecoveriX Treatment Provides Safer Alternative To Medications For Stroke And MS Patients","datePublished":"2024-01-18T17:10:14+00:00","mainEntityOfPage":{"@id":"https:\/\/urbancare.clinic\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\/"},"wordCount":727,"publisher":{"@id":"https:\/\/urbancare.clinic\/#organization"},"image":{"@id":"https:\/\/urbancare.clinic\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\/#primaryimage"},"thumbnailUrl":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2024\/01\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients.jpg","articleSection":["Medical Daily"],"inLanguage":"de"},{"@type":"WebPage","@id":"https:\/\/urbancare.clinic\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\/","url":"https:\/\/urbancare.clinic\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\/","name":"Neurotechnologiebasierte RecoveriX-Behandlung bietet sicherere Alternative zu Medikamenten f\u00fcr Schlaganfall- und MS-Patienten \u2013 Urban Care Clinic","isPartOf":{"@id":"https:\/\/urbancare.clinic\/#website"},"primaryImageOfPage":{"@id":"https:\/\/urbancare.clinic\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\/#primaryimage"},"image":{"@id":"https:\/\/urbancare.clinic\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\/#primaryimage"},"thumbnailUrl":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2024\/01\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients.jpg","datePublished":"2024-01-18T17:10:14+00:00","breadcrumb":{"@id":"https:\/\/urbancare.clinic\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/urbancare.clinic\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/urbancare.clinic\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\/#primaryimage","url":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2024\/01\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients.jpg","contentUrl":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2024\/01\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients.jpg","caption":"Neurotechnology-Based RecoveriX Treatment Provides Safer Alternative To Medications For Stroke And MS Patients"},{"@type":"BreadcrumbList","@id":"https:\/\/urbancare.clinic\/neurotechnology-based-recoverix-treatment-provides-safer-alternative-to-medications-for-stroke-and-ms-patients\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/urbancare.clinic\/"},{"@type":"ListItem","position":2,"name":"Neurotechnology-Based RecoveriX Treatment Provides Safer Alternative To Medications For Stroke And MS Patients"}]},{"@type":"WebSite","@id":"https:\/\/urbancare.clinic\/#website","url":"https:\/\/urbancare.clinic\/","name":"St\u00e4dtische Pflegeklinik","description":"Ihre medizinische Gesundheitsklinik in Sansibar","publisher":{"@id":"https:\/\/urbancare.clinic\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/urbancare.clinic\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/urbancare.clinic\/#organization","name":"Urban Care Clinic Sansibar","alternateName":"Urban Care Clinic","url":"https:\/\/urbancare.clinic\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/urbancare.clinic\/#\/schema\/logo\/image\/","url":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2022\/07\/Urban-Care-Clinic-Logo-Trans-512x512-1.png","contentUrl":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2022\/07\/Urban-Care-Clinic-Logo-Trans-512x512-1.png","width":500,"height":500,"caption":"Urban Care Clinic Zanzibar"},"image":{"@id":"https:\/\/urbancare.clinic\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/urbancarezanzibar"]},{"@type":"Person","@id":"https:\/\/urbancare.clinic\/#\/schema\/person\/a304a61bcf298680ee41e2e9ae193930","name":"St\u00e4dtische Pflegeklinik","image":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/secure.gravatar.com\/avatar\/8f8b5f9c42679ce61ae24fd31561a4574502595c4b3428a4fdf92d929bf09352?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8f8b5f9c42679ce61ae24fd31561a4574502595c4b3428a4fdf92d929bf09352?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8f8b5f9c42679ce61ae24fd31561a4574502595c4b3428a4fdf92d929bf09352?s=96&d=mm&r=g","caption":"Urban Care Clinic"},"url":"https:\/\/urbancare.clinic\/de\/author\/urban-care-clinic\/"}]}},"_links":{"self":[{"href":"https:\/\/urbancare.clinic\/de\/wp-json\/wp\/v2\/posts\/9257","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/urbancare.clinic\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/urbancare.clinic\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/urbancare.clinic\/de\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/urbancare.clinic\/de\/wp-json\/wp\/v2\/comments?post=9257"}],"version-history":[{"count":0,"href":"https:\/\/urbancare.clinic\/de\/wp-json\/wp\/v2\/posts\/9257\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/urbancare.clinic\/de\/wp-json\/wp\/v2\/media\/9258"}],"wp:attachment":[{"href":"https:\/\/urbancare.clinic\/de\/wp-json\/wp\/v2\/media?parent=9257"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/urbancare.clinic\/de\/wp-json\/wp\/v2\/categories?post=9257"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/urbancare.clinic\/de\/wp-json\/wp\/v2\/tags?post=9257"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}